Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

NCT00030459 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2013-08-07

No results posted yet for this study

Summary

RATIONALE: Palliative therapy may help patients with advanced cancer live more comfortably. It is not yet known if palliative therapy is more effective with or without chemotherapy in treating patients who have malignant mesothelioma.

PURPOSE: Randomized phase II trial to compare the effectiveness of palliative therapy with or without different chemotherapy regimens in treating patients who have malignant mesothelioma.

Conditions

  • Malignant Mesothelioma

Interventions

DRUG

cisplatin

DRUG

mitomycin C

DRUG

vinblastine sulfate

DRUG

vinorelbine tartrate

Sponsors & Collaborators

Principal Investigators

  • Martin F. Muers, MD · Leeds General Infirmary

  • David J. Girling, MD · Medical Research Council

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00030459 on ClinicalTrials.gov